Peripartum mood disturbances interventions: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ {{Peripartum mood disturbances}} {{CMG}}; {{AE}}{{Sunita}} ==Overview== There are no recommended therapeutic interventions for the management of [disease name]. OR...")
 
No edit summary
Line 30: Line 30:
{{WH}}
{{WH}}
{{WS}}
{{WS}}
[[Category:Primary care]]
[[Category:Obstetrics]]
[[Category:Medicine]]
[[Category:Up-To-Date]]
[[Category:Psychiatry]]

Revision as of 15:31, 29 July 2021

Peripartum mood disturbances Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Peripartum mood disturbances from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Peripartum mood disturbances interventions On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Peripartum mood disturbances interventions

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Peripartum mood disturbances interventions

CDC on Peripartum mood disturbances interventions

Peripartum mood disturbances interventions in the news

Blogs on Peripartum mood disturbances interventions

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Peripartum mood disturbances interventions

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sunita Kumawat, M.B.B.S[2]

Overview

There are no recommended therapeutic interventions for the management of [disease name].

OR

[name of intervention] is not the first-line treatment option for patients with [disease name]. [name of intervention] is usually reserved for patients with either [indication 1], [indication 2], and/or [indication 3].

OR

The mainstay of treatment for [disease name] is medical therapy/surgery. [Name of intervention] is usually reserved for patients with either [indication 1], [indication 2], and/or [indication 3].

OR

The feasibility of [name of intervention] depends on the stage of [disease or malignancy] at the time of diagnosis.

OR

[Name of intervention] is the mainstay of treatment for [disease or malignancy].

Indications

The mainstay of treatment for TT is medical therapy.

References

Template:WH Template:WS